The Latest Breaking News from telehealth

At least four congressional committees are working on mental health bills, but the list of priorities is growing.

CVS Health Corp. (NYSE: CVS) has stopped filling prescriptions for controlled substances requested by clinicians from the telehealth startup companies Cerebral Inc. and Done Health.

Doximity Inc (NYSE:DOCS) reported fourth-quarter revenue growth of 40.4% year-over-year to $93.7 million, beating the consensus of $90.11 million. Adjusted net income was $44.9 million versus $24 million in 4Q21, representing a 48% margin. Adjusted EPS was $0.21, beating the consensus of $0.15. Adjusted gross margin expanded by 200 bps to 90%.…

Psychiatrists say a Medicare cut has been devastating for vulnerable patients across rural and regional Australia.

WASHINGTON — Members of vulnerable and hard-to-reach groups could find it more difficult to get treatment for substance use disorders if the end of the public health emergency also brings the end of policies that allow health care providers to prescribe medications through video or audio calls, experts say.

The end of the pandemic may make it harder for vulnerable populations to have access to medication-assisted treatment for drug addiction.

Medical staff say western NSW health system is so under resourced patients are palmed from hospital to hospital

Cerebral told clinicians it will stop prescribing Adderall and other controlled substances to treat ADHD for new patients.

The company says it will continue to prescribe controlled substances for other conditions.